ACSL6 anticorps (AA 240-270)

N° du produit ABIN5647457

Cet anticorps anti-ACSL6 est un anticorps Lapin Polyclonal détectant ACSL6 dans WB, ELISA et IHC. Adapté pour Humain et Souris.

Aperçu rapide pour ACSL6 anticorps (AA 240-270) (ABIN5647457)

Antigène: ACSL6 (Acyl-CoA Synthetase Long-Chain Family Member 6 (ACSL6))

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp ACSL6 est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Détail du produit anti-ACSL6 anticorps

Épitope: AA 240-270

Purification: Purified

Immunogène: A portion of amino acids 240-270 from the human protein was used as the immunogen for this ACSL6 antibody.

Isotype: Ig Fraction

Information d'application

Indications d'application: Western blot: 1:1000,IHC (Paraffin): 1:50-1:100

Restrictions: For Research Use only

Stockage

Buffer: In 1X PBS, pH 7.4, with 0.09 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the ACSL6 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.

Détails sur ACSL6

Antigène: ACSL6 (Acyl-CoA Synthetase Long-Chain Family Member 6 (ACSL6))

Autre désignation: ACSL6 / FACL6

Sujet: FACL6 is involved in activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. It plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid. FACL6 is expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derieved from fetal liver, haemopoietic stem cells from cord blood, bone marrow, and brain. Expression is low at earlier stages of erythroid development but is very high in reticulocytes. This protein is involved in myelodysplastic syndrome (MDS) with basophilia, acute myelogenous leukemia (AML) with eosinophilia, and acute eosinophilic leukemia (AEL). It is characterized by a chromosomal translocation t(5,12)(q31,p13) that involves ETV6 and ACSL6.

UniProt: Q9UKU0